A Feasibility Study on the Use of Equine Chondrogenic Induced Mesenchymal Stem Cells as a Treatment for Natural Occurring Osteoarthritis in Dogs

<div>Box plot representation of (a) the stance time, (b) the stride length, (c) the pressure %, (d) the GAIT4Dog lameness score, (e) the reach, and (f) the stance % measured with the pressure plate analysis at baseline (day 0), after placebo control product (CP) administration (week 6) and after xenogeneic chondrogenic induced mesenchymal stem cell (ciMSC) administration (week 12). No significant differences were noted in any of the parameters between CP treatment and ciMSC treatment.</div>

Stem Cells International

fig1

Figure 1

Figure 1: A Feasibility Study on the Use of Equine Chondrogenic Induced Mesenchymal Stem Cells as a Treatment for Natural Occurring Osteoarthritis in Dogs 

Figure 1 | A Feasibility Study on the Use of Equine Chondrogenic Induced Mesenchymal Stem Cells as a Treatment for Natural Occurring Osteoarthritis in Dogs 